Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 11, Issue 1, 2009, Pages

  Lopez, Javier E ^a   Yeo, Khung ^a   Caputo, Gary ^b   Buonocore, Michael ^b   Schaefer, Saul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; METHAMPHETAMINE; CENTRAL STIMULANT AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CASE REPORT; CELL DAMAGE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HUMAN; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL DYSPNEA; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SYSTOLIC HEART MURMUR; THORAX RADIOGRAPHY; TOBACCO; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HOSPITALIZATION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; TIME; TREATMENT OUTCOME;

ADULT; CARDIOMYOPATHIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; METHAMPHETAMINE; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 74049134983     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-11-46     Document Type: Article

References (20)

1. Methamphetamine abuse: an overview for health care professionals. DA Wolkoff, Hawaii Med J 1997 56 34 36 9063008
2. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). DB Diercks GC Fonarow JD Kirk P Jois-Bilowich JE Hollander JE Weber J Wynne RM Mills C Yancy WF Peacock, Am J Cardiol 2008 102 1216 1219 10.1016/j.amjcard.2008.06.045 18940295
3. The association of methamphetamine use and cardiomyopathy in young patients. KK Yeo M Wijetunga H Ito JT Efird K Tay TB Seto K Alimineti C Kimata IJ Schatz, Am J Med 2007 120 165 171 10.1016/j.amjmed.2006.01.024 17275458
4. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. SB Karch BG Stephens CH Ho, J Forensic Sci 1999 44 359 368 10097363
5. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. SD Turnipseed JR Richards JD Kirk DB Diercks EA Amsterdam, J Emerg Med 2003 24 369 373 10.1016/S0736-4679(03)00031-3 12745036
6. Acute coronary syndrome and crystal methamphetamine use: a case series. M Wijetunga R Bhan J Lindsay S Karch, Hawaii Med J 2004 63 8 13 15011896
7. Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. S Srikanth R Barua J Ambrose, Cardiology 2008 109 188 192 10.1159/000106681 17728543
8. Reversible dilated cardiomyopathy induced by methamphetamine. LJ Jacobs, Clin Cardiol 1989 12 725 727 10.1002/clc.4960121211 2612079
9. Cardiomyopathy associated with the smoking of crystal methamphetamine. R Hong E Matsuyama K Nur, JAMA 1991 265 1152 1154 10.1001/jama.265.9.1152 1996001
10. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Y Maeno M Iwasa H Inoue H Koyama R Matoba, Int J Legal Med 2000 113 201 207 10.1007/s004149900088 10929235
11. Cardiac lesions and their reversibility after long term administration of methamphetamine. MN Islam H Kuroki B Hongcheng Y Ogura N Kawaguchi S Onishi C Wakasugi, Forensic Sci Int 1995 75 29 43 10.1016/0379-0738(95)01765-B 7590547
12. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. SY He R Matoba N Fujitani K Sodesaki S Onishi, Am J Forensic Med Pathol 1996 17 155 162 10.1097/00000433-199606000-00014 8727293
13. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. JA McCrohon JC Moon SK Prasad WJ McKenna CH Lorenz AJ Coats DJ Pennell, Circulation 2003 108 54 59 10.1161/01.CIR.0000078641.19365.4C 12821550
14. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. H Mahrholdt A Wagner RM Judd U Sechtem RJ Kim, Eur Heart J 2005 26 1461 1474 10.1093/eurheartj/ehi258 15831557
15. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. KC Wu RG Weiss DR Thiemann K Kitagawa A Schmidt D Dalal S Lai DA Bluemke G Gerstenblith E Marban GF Tomaselli JA Lima, J Am Coll Cardiol 2008 51 2414 2421 18565399 10.1016/j.jacc.2008.03.018
16. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. RJ Kim E Wu A Rafael EL Chen MA Parker O Simonetti FJ Klocke RO Bonow RM Judd, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
17. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. LS Seiden KE Sabol, NIDA Res Monogr 1996 163 251 276 8809863
18. A report of 2 cases of transient mid-ventricular ballooning. A Tamura Y Kawano T Watanabe T Aso Y Abe S Yano J Kadota, Int J Cardiol 2007 122 10 12 10.1016/j.ijcard.2006.11.060 17240466
19. Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. M Hernandez-Pampaloni JJ Bax K Morita DP Dutka PG Camici, Eur J Nucl Med Mol Imaging 2005 32 314 321 10.1007/s00259-004-1682-y 15791441
20. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M, Kim RJ: Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003, 108:1945-1953.